Effect of combined atabrine-antimicrobial drug therapy on urinary tract infections: in vitro and in vivo studies.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011796:Quinacrine / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D000667:Ampicillin; D009582:Nitrofurantoin; D011796:Quinacrine; D002512:Cephalothin